Health Trials

Cardiac Ablation

2

Review clinical trials related to Cardiac Ablation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System

The objective of this study is to demonstrate the safety and effectiveness of the CellFX nano-second Pulsed Field Ablation (nsPFA) Cardiac Catheter Ablation System in treating recurrent, drug-resistant, symptomatic paroxysmal atrial fibrillation (AF).

Participants needed: 215
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Pulse Biosciences, Inc.Updated: May 6, 2026Locations: 1
Eligibility criteria

Age 18 through 85 years old (or older than 18 if required by local law) [+3]

Left atrial diameter ≥5.5 cm (anteroposterior) [+35]

Read more
Status: Recruiting

CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation

The objective of this study is to demonstrate initial safety and effectiveness of the CellFX nano-second Pulsed Field Ablation (nsPFA or nano-PFA) 360 Catheter Endocardial Ablation System in treating subjects with atrial fibrillation.

Participants needed: 60
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Pulse Biosciences, Inc.Updated: May 5, 2026Locations: 3
Eligibility criteria

Subject must be ≥ 18 and ≤ 75 years of age on the day of enrollment [+6]

Subject has an implantable electronic medical device. (i.e., pacemaker, ICD or C... [+31]

Read more